SE9804192D0 - New formulation - Google Patents

New formulation

Info

Publication number
SE9804192D0
SE9804192D0 SE9804192A SE9804192A SE9804192D0 SE 9804192 D0 SE9804192 D0 SE 9804192D0 SE 9804192 A SE9804192 A SE 9804192A SE 9804192 A SE9804192 A SE 9804192A SE 9804192 D0 SE9804192 D0 SE 9804192D0
Authority
SE
Sweden
Prior art keywords
cyclosporin
composition
monoglycerides
lipids
new formulation
Prior art date
Application number
SE9804192A
Other languages
English (en)
Inventor
Bengt Hersloef
Peter Kaufmann
Carl-Gunnar Kroon
Original Assignee
Scotia Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Lipidteknik Ab filed Critical Scotia Lipidteknik Ab
Priority to SE9804192A priority Critical patent/SE9804192D0/sv
Publication of SE9804192D0 publication Critical patent/SE9804192D0/sv
Priority to NZ512194A priority patent/NZ512194A/xx
Priority to JP2000584910A priority patent/JP2002531412A/ja
Priority to PCT/SE1999/002259 priority patent/WO2000032219A1/en
Priority to EP99963798A priority patent/EP1135152A1/en
Priority to PL99348062A priority patent/PL348062A1/xx
Priority to AU20167/00A priority patent/AU764413B2/en
Priority to HU0105399A priority patent/HUP0105399A3/hu
Priority to CA002352388A priority patent/CA2352388A1/en
Priority to NO20012736A priority patent/NO20012736D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
SE9804192A 1998-12-03 1998-12-03 New formulation SE9804192D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9804192A SE9804192D0 (sv) 1998-12-03 1998-12-03 New formulation
NZ512194A NZ512194A (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier
JP2000584910A JP2002531412A (ja) 1998-12-03 1999-12-03 脂質キャリヤー中にサイクロスポリンを含む医薬組成物
PCT/SE1999/002259 WO2000032219A1 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier
EP99963798A EP1135152A1 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier
PL99348062A PL348062A1 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier
AU20167/00A AU764413B2 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier
HU0105399A HUP0105399A3 (en) 1998-12-03 1999-12-03 Pharmaceutical composition comprising cyclosporin in a lipid carrier
CA002352388A CA2352388A1 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier
NO20012736A NO20012736D0 (no) 1998-12-03 2001-06-01 Farmasöytisk blanding omfattende cyklosporin i en lipidb¶rer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804192A SE9804192D0 (sv) 1998-12-03 1998-12-03 New formulation

Publications (1)

Publication Number Publication Date
SE9804192D0 true SE9804192D0 (sv) 1998-12-03

Family

ID=20413540

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9804192A SE9804192D0 (sv) 1998-12-03 1998-12-03 New formulation

Country Status (10)

Country Link
EP (1) EP1135152A1 (sv)
JP (1) JP2002531412A (sv)
AU (1) AU764413B2 (sv)
CA (1) CA2352388A1 (sv)
HU (1) HUP0105399A3 (sv)
NO (1) NO20012736D0 (sv)
NZ (1) NZ512194A (sv)
PL (1) PL348062A1 (sv)
SE (1) SE9804192D0 (sv)
WO (1) WO2000032219A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
SE0303135D0 (sv) * 2003-11-25 2003-11-25 Lipocore Holding Ab Controlled food effect composition
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
JP2008539230A (ja) * 2005-04-28 2008-11-13 ガレニカ テクノロジー アンチエボラグ 脂質相を含む薬学的投与形態
EP2699267A4 (en) * 2011-04-18 2014-11-12 Lipidor Ab LIQUID CARRIER FOR THE ORAL DELIVERY OF A PHARMACOLOGICAL ACTIVE SUBSTANCE
JP6242581B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
WO2014103742A1 (ja) * 2012-12-25 2014-07-03 ポーラ化成工業株式会社 逆ベシクル組成物及びその製造方法
JP6334151B2 (ja) * 2012-12-25 2018-05-30 ポーラ化成工業株式会社 逆ベシクル組成物
JP6242582B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5529785A (en) * 1993-05-12 1996-06-25 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
EP0743851B1 (en) * 1994-02-04 2001-06-13 Scotia Lipidteknik Ab Lipophilic carrier preparations
IL115742A (en) * 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Also Published As

Publication number Publication date
NZ512194A (en) 2002-09-27
WO2000032219A1 (en) 2000-06-08
NO20012736L (no) 2001-06-01
HUP0105399A2 (en) 2002-06-29
HUP0105399A3 (en) 2005-06-28
PL348062A1 (en) 2002-05-06
JP2002531412A (ja) 2002-09-24
CA2352388A1 (en) 2000-06-08
AU2016700A (en) 2000-06-19
AU764413B2 (en) 2003-08-21
NO20012736D0 (no) 2001-06-01
EP1135152A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
IS6344A (is) Lyfjasamsetningar sem leiða til aukinna lyfjastyrkja
RS49838B (sr) Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
AU2845599A (en) Pharmaceutical compositions and their use
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
DK0851753T3 (da) Aerosolpræparater
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
NZ509418A (en) Pharmaceutical formulations for aerosols with two or more active substances
ATE226815T1 (de) Herstellung von arzneimitteln
DE69928554D1 (de) Therapeutische formulierung enthaltende dosierungsform
SE9804192D0 (sv) New formulation
DE60126433D1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
BR0111678A (pt) Composições medicinais contendo derivados de propenona
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
SE9800729D0 (sv) New topical formulation I
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
DE69616783D1 (de) Osmotische vorrichtung mit hohem gehalt an wirkstoffen und verzögertem aktivieren der wirkstofffreisetzung
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
ATE227509T1 (de) Inhibitor- und konservierungsmittelzusammensetzung
KR970061251A (ko) 항진균성 외용 조성물
DE59801586D1 (de) Zur topischen applikation bestimmte diclofenac-lösung
AR000922A1 (es) Productos para combatir hongos nocivos que contienen derivados de p-hidroxifenilanilina como agente activo, aplicacion de dichos derivados paracombatir hongos nocivos y procedimiento para combatir hongos nocivos con aplicacion de dichos productos.